Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LXRX | AMGN | VRTX | GILD | BMY |
| Company | Lexicon Pharmaceutcl | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.7212 | 262.18 | 403.14 | 92.62 | 56.93 |
| High | 0.7749 | 263.58 | 409.60 | 92.83 | 57.38 |
| Low | 0.7208 | 260.12 | 402.72 | 91.74 | 56.73 |
| Last | 0.7905 | 260.77 | 405.20 | 91.99 | 57.14 |
| Change | +0.0520 | +0.13 | +2.50 | -0.38 | +0.58 |
| % Change | +7.04% | +0.05% | +0.62% | -0.41% | +1.03% |
| Volume | 863,423 | 679,441 | 401,759 | 762,437 | 1,986,804 |
| 20-Day Average Volume | 5,226,994 | 3,670,202 | 1,841,795 | 6,658,080 | 10,902,324 |
| Previous Close | 0.7385 | 260.64 | 402.70 | 92.37 | 56.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7512 | 267.36 | 437.30 | 92.41 | 57.34 |
| 20-Day Raw Stochastic | 38.19% | 26.93% | 29.58% | 52.27% | 40.57% |
| 20-Day Relative Strength | 42.28% | 32.11% | 35.99% | 51.83% | 50.72% |
| Weighted Alpha | -53.11 | -19.02 | -9.54 | +19.85 | +16.54 |
| Today's Opinion | 88% Sell | 88% Sell | 72% Sell | 88% Buy | 72% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 72% Sell | 88% Buy | 56% Buy |
| Last Month's Opinion | 100% Sell | 72% Sell | 8% Sell | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.01% since 12/24/24 | -1.51% since 12/24/24 | -0.29% since 12/24/24 | -2.05% since 12/24/24 | -1.39% since 12/24/24 |
| Low | 0.7000 on 12/26/24 | 258.50 on 12/30/24 | 399.06 on 12/30/24 | 91.72 on 12/30/24 | 55.93 on 12/31/24 |
| High | 0.8169 on 12/27/24 | 264.73 on 12/26/24 | 411.29 on 12/26/24 | 94.55 on 12/26/24 | 58.38 on 12/27/24 |
| 1-Month | |||||
| %Chg | -3.48% since 12/02/24 | -6.33% since 12/02/24 | -12.61% since 12/02/24 | -2.12% since 12/02/24 | -4.98% since 12/02/24 |
| Low | 0.6204 on 12/05/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 89.15 on 12/13/24 | 55.04 on 12/13/24 |
| High | 1.0200 on 12/11/24 | 281.38 on 12/03/24 | 476.46 on 12/10/24 | 94.65 on 12/11/24 | 60.09 on 12/03/24 |
| 3-Month | |||||
| %Chg | -51.99% since 10/02/24 | -18.53% since 10/02/24 | -11.93% since 10/02/24 | +8.60% since 10/02/24 | +5.94% since 10/02/24 |
| Low | 0.6204 on 12/05/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 83.98 on 10/04/24 | 51.31 on 10/15/24 |
| High | 2.1750 on 10/18/24 | 329.17 on 10/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | -51.69% since 07/02/24 | -16.18% since 07/02/24 | -14.09% since 07/02/24 | +34.54% since 07/02/24 | +40.80% since 07/02/24 |
| Low | 0.6204 on 12/05/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 66.01 on 07/05/24 | 39.35 on 07/05/24 |
| High | 2.4500 on 07/25/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 181,846 | 140,102,608 | 103,706,928 | 115,117,592 | 114,713,688 |
| Shares Outstanding, K | 246,237 | 537,533 | 257,529 | 1,246,266 | 2,028,177 |
| Annual Sales | 1,200,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -177,120,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 1,750,000 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -64,810,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | 1.07 | 0.55 | 0.36 | 0.18 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 11/12/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 11/12/24 | 02/04/25 | 02/03/25 | 02/11/25 | 02/06/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.770 on 12/13/24 | 0.620 on 01/03/25 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 12/13/24 | 01/03/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.49 | 0.00 | 20.77 | 47.91 |